Future Financial Wealth Managment LLC Raises Stock Holdings in Humana Inc. (NYSE:HUM)

Future Financial Wealth Managment LLC grew its position in shares of Humana Inc. (NYSE:HUM) by 20.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 600 shares of the insurance provider’s stock after acquiring an additional 100 shares during the quarter. Future Financial Wealth Managment LLC’s holdings in Humana were worth $152,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of HUM. Creative Financial Designs Inc. ADV lifted its stake in shares of Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. Atwood & Palmer Inc. purchased a new position in Humana during the third quarter worth $29,000. Ashton Thomas Securities LLC bought a new position in Humana during the third quarter valued at $31,000. Your Advocates Ltd. LLP raised its stake in shares of Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares during the period. Finally, Hollencrest Capital Management bought a new stake in shares of Humana in the 2nd quarter worth about $40,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HUM. KeyCorp began coverage on Humana in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Oppenheimer dropped their price objective on Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a report on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft decreased their target price on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 target price on shares of Humana in a research report on Tuesday, October 1st. Finally, Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $302.00.

Humana Stock Performance

Shares of Humana stock traded up $19.73 during midday trading on Monday, hitting $288.77. The company had a trading volume of 1,336,229 shares, compared to its average volume of 1,263,237. The company has a fifty day simple moving average of $273.25 and a 200 day simple moving average of $310.27. The stock has a market cap of $34.77 billion, a price-to-earnings ratio of 25.58, a PEG ratio of 2.12 and a beta of 0.55. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $455.53.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, analysts predict that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.23%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.